Steroid use and long-term health risks in former athletes

Sports Medicine

Volumn 32, Issue 2, 2002, Pages 83-94

  Pärssinen, Miia ^a   Seppälä, Timo ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; STEROID; TESTOSTERONE;

ADULT; ATHLETE; CARDIOVASCULAR RISK; COMPETITION; CORONARY RISK; DOPING; DRUG ABUSE; DRUG DEPENDENCE; HEALTH HAZARD; HEART HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MORTALITY; PHYSICAL ACTIVITY; QUALITY OF LIFE; REVIEW; SPORTS MEDICINE; SUDDEN DEATH; THROMBOSIS; TOXICITY TESTING; WEIGHT LIFTING;

EID: 0036176027     PISSN: 01121642     EISSN: None     Source Type: Journal    
DOI: 10.2165/00007256-200232020-00001     Document Type: Review

References (61)

1. About anabolic steroid abuse [Tearoff]
2. The effects of supraphysiological doses of testosterone on muscle size and strength in normal men
3. Androgen receptor and mechanism of androgen action
4. The effects of 17α-methyltestosterone on myocardial function in vitro
5. Cardiovascular effects of androgenic-anabolic steroids
6. The cardiac toxicity of anabolic steroids
7. Psychological and behavioural effects of endogenous testosterone and anabolic-androgenic steroids
8. Evaluation of acute and chronic hepatotoxic effects exerted by anabolic-androgenic steroid stanozolol in adult male rats
9. Exposure to anabolic-androgenic steroids shortens life span of male mice
10. Anabolic steroids
11. Anabolic steroids and growth hormone
12. Anabolic steroids: A review of the literature
13. Adverse effects of anabolic steroids
14. Increased life expectancy of world class male athletes
15. Healthy lifestyles of former Finnish world class athletes
16. Prevalence of diabetes, hypertension, and ischemic heart disease in former elite athletes
17. Sudden cardiac death and the 'athlete's heart'
18. Relationship of skeletal muscle fiber type to serum high density lipoprotein cholesterol and apolipoprotein A-I levels
19. Association between skeletal muscle properties, physical fitness, physical activity and coronary heart disease risk factors in men
20. Muscle fiber type and aetiology of obesity
21. Natural selection to sports, later physical activity habits and coronary heart disease
22. Cardiovascular effects of anabolic steroids in weight-trained subjects
23. Echocardigraphy in fraternal twin bodybuilders with one abusing anabolic steroids
24. Left ventricular wall thickening does occur in elite power athletes with or without anabolic steroid use
25. Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters
26. Relation of dispersion of QRS and QT in patients with advanced congestive heart failure to cardiac and sudden death mortality
27. QT interval and QT dispersion in endurance athletes and in power athletes using large doses of anabolic steroids
28. Ventricular thrombosis and systemic embolism in bodybuilders: Etiology and management
29. Performance enhancing drugs (doping agents) and sudden death: A case report and review of the literature
30. Sudden death in young competitive athletes, clinical, demographic and pathological profiles
31. Risk for sudden cardiac death associated with marathon running
32. Sudden cardiac death in athletes
33. Sudden death and physical activity in athletes and nonathletes
34. Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroids: Pathological and toxicological findings
35. Myocardial infarction and death of a body builder after using anabolic steroids
36. Anabolic-androgenic steroids and psychiatric-related effects: A review
37. Psychological moods and subjectively perceived behavioral and somatic changes accompanying anabolic-androgenic steroid use
38. Psychiatric and medical effects of anabolic-androgenic steroid use: A controlled study of 160 athletes
39. Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: A randomized controlled trial
40. Psychological and serum homovanillic acid changes in men administered androgenic steroids
41. Neuropsychiatric effects of anabolic steroids in male normal volunteers
42. Anabolic androgenic steroids and suicide
43. Cause and manner of death among users of anabolic androgenic steroids
44. Symptoms and correlates of anabolic-androgenic steroid dependence
45. Anabolic-androgenic steroid dependence
46. Epidemiological characteristics and risk factors of hepatocellular carcinoma
47. The epidemiology of soft tissue sarcoma
48. Expression of androgen receptor and its implication in hepatoma cells
49. Serum testosterone: Estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients
50. Multiple hepatic adenomas caused by long-term administration of androgenic steroids for aplastic anemia in association with familial adenomatous polyposis
51. Danazol and multiple hepatic adenomas: Peculiar clinical findings in an acromegalic patient
52. Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate cancer
53. Serum androgens: Associations with prostate cancer risk and hair patterning
54. Serum steroids in relation to prostate cancer risk in a case-control study
55. Anabolic steroid abuse and renal-cell carcinoma
56. Anabolic steroid abuse and renal cell carcinoma
57. Renal cell carcinoma following prolonged testosterone therapy
58. Intratesticular leiomyosarcoma in a young man after high dose doping with Oral-Turinabol: A case report
59. Increased premature mortality of competitive power lifters suspected to have used anabolic agents